Legal Opinion

Burroughs Wellcome Co. v. Barr Laboratories, Inc., and Novopharm, Inc. And Novopharm, Ltd.

Court of Appeals for the Federal Circuit

Decided December 15, 1994No. 93-1503 to 93-1505Published

1Opinion of the Court

40 F.3d 1223

32 U.S.P.Q.2d 1915

BURROUGHS WELLCOME CO., Plaintiff-Appellee,

v.

BARR LABORATORIES, INC., Defendant-Appellant,

and

Novopharm, Inc. and Novopharm, Ltd., Defendants-Appellants.

Nos. 93-1503 to 93-1505.

United States Court of Appeals,

Federal Circuit.

Nov. 22, 1994.

Rehearing Denied Dec. 15, 1994.

E. Anthony Figg, Rothwell, Figg, Ernst & Kurz, Washington, DC, argued for plaintiff-appellee. With him on the brief were Steven Lieberman and Joseph A. Hynds. Of counsel was Mark A. Ash. Also on the brief were Thomas F. Curnin, Laura Mezey, Daniel L. Cantor and Michael B. Weiss, Cahill, Gordon &…

Also in this document: Concurring in part, dissenting in part.

2Cases cited20 opinions

  1. Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
  2. The Read Corporation and F.T. Read & Sons, Inc. v. Portec, Inc., D/B/A Portec/kolberg DivisionCourt of Appeals for the Federal Circuit · 1992
  3. Hybritech Incorporated v. Monoclonal Antibodies, Inc.Court of Appeals for the Federal Circuit · 1986
  4. Amgen, Inc., Plaintiff/cross-Appellant v. Chugai Pharmaceutical Co., Ltd., and Genetics Institute, Inc.Court of Appeals for the Federal Circuit · 1991
  5. Burroughs Wellcome Co. v. Barr Laboratories, Inc., and Novopharm, Inc. And Novopharm, Ltd.Court of Appeals for the Federal Circuit · 1994

15 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API